Novel pharmacological strategies for motor complications in Parkinson’s disease

Author： Konitsiotis Spiros  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.4, 2005-04, pp. : 377-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Therapies in the Pharmacological Treatment of Parkinson’s Disease

By Korczyn A.D.   Nussbaum M.  

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 775-786

Adis International

Access to resources Recommend Favorite

Recent developments in the pharmacological treatment of Parkinson’s disease

By Tuite Paul   Riss Jennifer  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1335-1352

Informa Healthcare

Access to resources Recommend Favorite

Drug treatment of non-motor symptoms in Parkinson’s disease

By Müller Thomas  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. : 381-388

Informa Healthcare

Access to resources Recommend Favorite

A number of levodopa-based strategies may improve the management of motor complications in Parkinson's disease

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 11, 2010-11 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinson's Disease

By Antonini Angelo  

CNS Drugs, Vol. 24, Iss. 2, 2010-02 ,pp. : 119-129

Adis International

Access to resources Recommend Favorite